Research is being conducted on the effects of medication on the gut microbiome in patients undergoing allogeneic hematopoietic cell transplantation. The studies suggest that the gut microbiome may play a role in the development of complications, such as graft-versus-host disease, and that factors like antibiotic use and obesity may impact the microbiome's composition. The relationship between the gut microbiome and transplant outcomes is being explored, with potential implications for therapeutic targets and improving patient care.